Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Long-term Effects of Family WISH Program for Adolescents with Congenital Heart Disease

Study ID: NCT06719323
Start Date: 2025-12-01
End Date: 2027-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

104

Intervention / Treatment

Family Walking Instruction with Support by Heart (Family WISH) program

Comparison group

Sponsor

χ-wen Chen

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 Study of the Safety and Tolerability of MT-125 in GBM Patients

Study ID: NCT07185880
Start Date: 2025-11-01
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

MT-125

Sponsor

Myosin Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer

Study ID: NCT07090369
Start Date: 2025-11-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Olaparib (300 mg BID)

Pembrolizumab

177Lu-PSMA-I&T

Sponsor

Peter MacCallum Cancer Centre, Australia

Source: clinicaltrials.gov

Share:
Add to list

Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines

Study ID: NCT07142369
Start Date: 2025-10
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

99

Intervention / Treatment

Synovial Fluid withdrawal at the preoperative clinic visit

Platelet-Rich Plasma (PRP) preparation and injection

Synovial fluid withdrawal at the time of surgery

3mL synovial fluid withdrawn at the preoperative visit

Sponsor

Rush University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology

Study ID: NCT05046782
Start Date: 2026-02-28
End Date: 2027-02-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

302

Intervention / Treatment

restriction spectrum imaging (RSI)

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Single Implant Crowns Supported by Narrow or Standard Diameter Implants in Molar Sites

Study ID: NCT07073196
Start Date: 2025-10-01
End Date: 2029-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Dental implant treatment (narrow implants)

Dental implant treatment (standard implants)

Sponsor

Mohammed Bin Rashid University of Medicine and Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Study ID: NCT07143669
Start Date: 2025-09-30
End Date: 2028-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

450

Intervention / Treatment

Screening

Sponsor

Blueprint Medicines Corporation

Source: clinicaltrials.gov

Share:
Add to list

Multicentre Longitudinal Study of Bone Mineralisation Characteristics in Marfan Syndrome and Ehlers-Danlos Syndrome

Study ID: NCT07169669
Start Date: 2025-10-31
End Date: 2026-05-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

IRCCS Polyclinic San. Donate

Source: clinicaltrials.gov

Share:
Add to list

Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT

Study ID: NCT06872346
Start Date: 2025-10-01
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

7500

Intervention / Treatment

Visit-based IT reminders to patients and practitioners

Population outreach

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia

Study ID: NCT06744283
Start Date: 2025-10-01
End Date: 2026-01-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment
Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list